Treatment
Yehuda's Story Fearing he may never walk again, Yehuda overcomes Ewing's sarcoma |  |  |
|
|
Once a diagnosis of Ewing's sarcoma has been confirmed, patients will be treated with chemotherapy to shrink the tumor and to prevent new tumors from forming. Patients also undergo surgery to remove all areas of tumor involvement. Depending on the site of tumor involvement, radiation therapy may also be used to treat Ewing's sarcoma. Standard chemotherapy medications in Ewing's sarcoma include vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide. Patients treated for Ewing sarcoma here have the highest long-term survival rates in the nation -- an 85 percent five-year survival rate when treated with chemotherapy, surgery, and/or radiation therapy.
Treatment for patients with relapsed disease is individualized based on the therapy previously received. Additional surgery and/or radiation therapy are possible treatment approaches. Based on laboratory studies conducted here at Memorial Sloan-Kettering, we offer a series of innovative, disease-specific clinical trials for this group of high-risk patients.
